Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use

Update Item Information
Title Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use
Creator Albert S. Li, MD; Howard D. Pomeranz, MD, PhD
Affiliation Department of Ophthalmology, Northwell Health and Hofstra Northwell School of Medicine, Great Neck, New York
Subject Adverse Drug Reaction Reporting Systems / statistics & numerical data; Databases, Factual; Drug-Related Side Effects and Adverse Reactions / epidemiology; Humans; Phosphodiesterase 5 Inhibitors / adverse effects; Product Surveillance, Postmarketing; Pyrimidines / adverse effects; Retinal Artery Occlusion / chemically induced; Retinal Vein Occlusion / chemically induced; Sildenafil Citrate / adverse effects; Tadalafil / adverse effects; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride / adverse effects
OCR Text Show
Date 2016-12
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Source Journal of Neuro-Ophthalmology, December 2016, Volume 36, Issue 4
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s6zh0qsc
Setname ehsl_novel_jno
ID 1293166
Reference URL https://collections.lib.utah.edu/ark:/87278/s6zh0qsc
Back to Search Results